Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 3/2019

16.01.2019 | Case Report

Esophageal carcinosarcoma that disappeared pathologically by palliative radiotherapy alone

verfasst von: Keiichi Kimura, Yoshito Hayashi, Keisuke Otani, Yoshiki Tsujii, Hideki Iijima, Fumiaki Isohashi, Kazuhiko Ogawa, Tetsuo Takehara

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Only a few cases of esophageal granulocyte-colony-stimulating-factor (G-CSF)–producing esophageal carcinosarcoma are reported, and patients with G-CSF–producing tumors are typically considered to have poor prognosis. An 89-year-old man was examined for low-grade fever and dysphagia. Chest computed tomography revealed a huge 80-mm tumor on the thoracic esophagus without direct invasion to surrounding organs. Esophagogastroduodenoscopy (EGD) showed a huge mass occupying the esophageal lumen with a superficial flat lesion. Histopathological examination revealed that the tumor was composed of bizarre giant cells and pleomorphic spindle cells with hyperchromatic nuclei. Laboratory data showed aberrant elevation of leukocyte and neutrophil counts and G-CSF levels. The tumor was finally diagnosed as a G-CSF-producing esophageal carcinosarcoma, stage II (T2N0M0, Union for International Cancer Control-TNM Classification of Malignant Tumors, 8th edition). Considering his general condition, we performed palliative radiotherapy (45 Gy/15 fr) alone after consultation with surgeons and radiation oncologists. Follow-up EGD demonstrated the disappearance of the tumor, and the histological assessment of biopsy specimens confirmed no evidence of malignancy. The leukocyte count and G-CSF levels decreased within normal range. This is a very rare case of G-CSF-producing esophageal carcinosarcoma in which a pathologically complete response was achieved using palliative radiotherapy alone.
Literatur
1.
Zurück zum Zitat Iyomasa S, Kato H, Tachimori Y, et al. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990;20:99–106.PubMed Iyomasa S, Kato H, Tachimori Y, et al. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990;20:99–106.PubMed
2.
Zurück zum Zitat Matsutani T, Nomura T, Hagiwara N, et al. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography. J Nippon Med Sch. 2014;81:401–5.CrossRefPubMed Matsutani T, Nomura T, Hagiwara N, et al. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography. J Nippon Med Sch. 2014;81:401–5.CrossRefPubMed
3.
Zurück zum Zitat Ogasawara N, Tamura Y, Funaki Y, et al. Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone. Case Rep Gastroenterol. 2014;8:227–34.CrossRefPubMedPubMedCentral Ogasawara N, Tamura Y, Funaki Y, et al. Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone. Case Rep Gastroenterol. 2014;8:227–34.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sanada Y, Hihara J, Yoshida K, et al. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus. 2006;19:119–31.CrossRefPubMed Sanada Y, Hihara J, Yoshida K, et al. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus. 2006;19:119–31.CrossRefPubMed
5.
Zurück zum Zitat Patricia S, Saikat D, Rajesh B, et al. Rare cause of stricture esophagus-sarcoma: a case report and review of the literature. Case Rep Gastrointest Med. 2011; 2011:192423.PubMedPubMedCentral Patricia S, Saikat D, Rajesh B, et al. Rare cause of stricture esophagus-sarcoma: a case report and review of the literature. Case Rep Gastrointest Med. 2011; 2011:192423.PubMedPubMedCentral
6.
Zurück zum Zitat Kobayashi S, Nagata Y, Tokai H, et al. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep. 2015;3:681–5.CrossRefPubMedPubMedCentral Kobayashi S, Nagata Y, Tokai H, et al. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep. 2015;3:681–5.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ota S, Kato A, Kobayashi H, et al. Monoclonal origin of an esophageal carcinosarcoma producing granulocyte-colony stimulating factor: a case report. Cancer. 1998;82:2102–11.CrossRefPubMed Ota S, Kato A, Kobayashi H, et al. Monoclonal origin of an esophageal carcinosarcoma producing granulocyte-colony stimulating factor: a case report. Cancer. 1998;82:2102–11.CrossRefPubMed
8.
Zurück zum Zitat Maejima K, Watanabe M, Komine O, et al. Granulocyte-colony stimulating factor-producing esophageal carcinosarcoma: a case report. Esophagus. 2007;4:117–20.CrossRef Maejima K, Watanabe M, Komine O, et al. Granulocyte-colony stimulating factor-producing esophageal carcinosarcoma: a case report. Esophagus. 2007;4:117–20.CrossRef
9.
Zurück zum Zitat Sasaki K, Natsugoe S, Higashi M, et al. Esophageal carcinosarcoma with granulocyte colony-stimulating factor: a case report. Esophagus. 2007;4:129–34.CrossRef Sasaki K, Natsugoe S, Higashi M, et al. Esophageal carcinosarcoma with granulocyte colony-stimulating factor: a case report. Esophagus. 2007;4:129–34.CrossRef
10.
Zurück zum Zitat Miyamoto K, Shibata S, Kawasaki H. Carcinosarcoma of the esophagus producing granulocyte-colony stimulating factor: report of a case. Esophagus. 2008;5:171–5.CrossRef Miyamoto K, Shibata S, Kawasaki H. Carcinosarcoma of the esophagus producing granulocyte-colony stimulating factor: report of a case. Esophagus. 2008;5:171–5.CrossRef
11.
Zurück zum Zitat Cha RR, Jung WT, Oh HW, et al. A case of metachronous development of esophageal squamous cell carcinoma in the patient with esophageal carcinosarcoma. Korean J Gastroenterol. 2014;64:364–9.CrossRefPubMed Cha RR, Jung WT, Oh HW, et al. A case of metachronous development of esophageal squamous cell carcinoma in the patient with esophageal carcinosarcoma. Korean J Gastroenterol. 2014;64:364–9.CrossRefPubMed
12.
Zurück zum Zitat Ji F, Xu YM, Xu CF. Endoscopic polypectomy: a promising therapeutic choice for esophageal carcinosarcoma. World J Gastroenterol. 2009;15:3448–50.CrossRefPubMedPubMedCentral Ji F, Xu YM, Xu CF. Endoscopic polypectomy: a promising therapeutic choice for esophageal carcinosarcoma. World J Gastroenterol. 2009;15:3448–50.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Adan AK, Long AE, Weldon CB, et al. Esophageal carcinosarcoma. J Gastrointest Surg. 2001;5:414–7.CrossRef Adan AK, Long AE, Weldon CB, et al. Esophageal carcinosarcoma. J Gastrointest Surg. 2001;5:414–7.CrossRef
14.
Zurück zum Zitat Akagi I, Miyashita M, Makino H, et al. So-called carcinosarcoma of the esophagus: report of a case. J Nippon Med Sch. 2008;75:171–4.CrossRefPubMed Akagi I, Miyashita M, Makino H, et al. So-called carcinosarcoma of the esophagus: report of a case. J Nippon Med Sch. 2008;75:171–4.CrossRefPubMed
15.
Zurück zum Zitat Iascone C, Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus: two names, one disease–comprehensive review of the literature. World J Surg. 1999;23:153–7.CrossRefPubMed Iascone C, Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus: two names, one disease–comprehensive review of the literature. World J Surg. 1999;23:153–7.CrossRefPubMed
16.
Zurück zum Zitat Zhang B, Xiao Q, Yang D, et al. Spindle cell carcinoma of the esophagus: a multicenter analysis in comparison with typical squamous cell carcinoma. Medicine (Baltimore). 2016;95:e4768.CrossRef Zhang B, Xiao Q, Yang D, et al. Spindle cell carcinoma of the esophagus: a multicenter analysis in comparison with typical squamous cell carcinoma. Medicine (Baltimore). 2016;95:e4768.CrossRef
17.
Zurück zum Zitat Wang L, Lin Y, Long H, et al. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997–1004.CrossRefPubMed Wang L, Lin Y, Long H, et al. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997–1004.CrossRefPubMed
18.
Zurück zum Zitat Penniment MG, De Ieso PB, Harvey JA, et al. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3:114–24.CrossRefPubMed Penniment MG, De Ieso PB, Harvey JA, et al. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3:114–24.CrossRefPubMed
19.
Zurück zum Zitat Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99.CrossRefPubMedPubMedCentral Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925–31.CrossRefPubMedPubMedCentral Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925–31.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 1975;48:863–6.CrossRefPubMed Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 1975;48:863–6.CrossRefPubMed
22.
Zurück zum Zitat Bruton Joe M, Truong PT, et al Abscopal effect after palliative radiation therapy for metastatic adenocarcinoma of the esophagus. Cureus 2018; 10(8):e3089.PubMedPubMedCentral Bruton Joe M, Truong PT, et al Abscopal effect after palliative radiation therapy for metastatic adenocarcinoma of the esophagus. Cureus 2018; 10(8):e3089.PubMedPubMedCentral
23.
Zurück zum Zitat Takahashi Y, Yasui T, Tamari K, et al. Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma. PLoS One. 2017;12:e0189697.CrossRefPubMedPubMedCentral Takahashi Y, Yasui T, Tamari K, et al. Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma. PLoS One. 2017;12:e0189697.CrossRefPubMedPubMedCentral
Metadaten
Titel
Esophageal carcinosarcoma that disappeared pathologically by palliative radiotherapy alone
verfasst von
Keiichi Kimura
Yoshito Hayashi
Keisuke Otani
Yoshiki Tsujii
Hideki Iijima
Fumiaki Isohashi
Kazuhiko Ogawa
Tetsuo Takehara
Publikationsdatum
16.01.2019
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 3/2019
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00933-7

Weitere Artikel der Ausgabe 3/2019

Clinical Journal of Gastroenterology 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.